MedPath

Sodium phosphate, dibasic, unspecified form

Generic Name
Sodium phosphate, dibasic, unspecified form
Brand Names
Bss Ophthalmic Solution, Fleet Mineral Oil, Intersol, Isolyte S, Isoplate, Rejuvesol
Drug Type
Small Molecule
CAS Number
10140-65-5
Unique Ingredient Identifier
GR686LBA74

Overview

No overview information available.

Background

No background information available.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

FDA Approved Products

Solucion InterSol
Manufacturer:Fenwal, Inc.
Route:INTRAVENOUS
Strength:305 mg in 100 mL
Approved: 2021/10/04
NDC:0942-9603
Levobunolol Hydrochloride
Manufacturer:Bausch & Lomb Incorporated
Route:OPHTHALMIC
Approved: 2022/10/31
NDC:24208-505
InterSol
Manufacturer:Fenwal, Inc.
Route:INTRAVENOUS
Strength:305 mg in 100 mL
Approved: 2021/11/16
NDC:0942-9601
Isoplate
Manufacturer:Terumo BCT Ltd.
Route:INTRAVENOUS
Strength:0.008 g in 100 mL
Approved: 2015/05/08
NDC:14537-408

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath